Efficacy and Safety of Immune Checkpoint Inhibitor in Advanced Esophageal Squamous Cell Carcinoma: A Meta-Analysis

BACKGROUND: The published evidence from several randomized controlled clinical trials of immunotherapy for advanced esophageal squamous cell carcinoma has shown promising results. This study aimed to investigate the efficacy and safety of immune checkpoint inhibitor treatment in esophageal squamous...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yi-Min, Shang, Qi-Xin, Zhuo, Yue, Zhou, Jian-Feng, Liu, Bo-Wei, Wang, Wen-Ping, Che, Guo-Wei, Chen, Long-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724211/
https://www.ncbi.nlm.nih.gov/pubmed/34993139
http://dx.doi.org/10.3389/fonc.2021.777686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724211/
https://www.ncbi.nlm.nih.gov/pubmed/34993139
http://dx.doi.org/10.3389/fonc.2021.777686

Ejemplares similares